Results 161 to 170 of about 60,163 (379)

Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF

ESC Heart Failure, EarlyView.
Abstract Aims Implantable cardioverter‐defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of optimized medical therapy (OMT).
Diogo Rosa Ferreira, Daniel Inácio Cazeiro, Joana Brito, Rafael Santos, Joana Rigueira, Doroteia Silva, Nuno Lousada, Fausto Pinto, Dulce Brito, João Agostinho   +9 more
wiley   +1 more source

Biological defibrillation [PDF]

European Heart Journal, 2018
Nyns, E.C.A., Vries, A.A.F. de, Pijnappels, D.A.   +2 more
openaire   +3 more sources

Novel mutation associated with non‐compaction ventricular myocardium: A case report

ESC Heart Failure, EarlyView.
Yan Li, Xi Wang, Saiyong Chen, Chun Wu, Fushi Piao   +4 more
wiley   +1 more source

Public Access Defibrillation Programs: Improving Outcomes Worldwide [PDF]

, 2015
Santiago O. Valdés
openalex   +1 more source

Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study

ESC Heart Failure, EarlyView.
In this prospective registry of 1401 heart failure outpatients, patients with eGFR <60 mL/min/1.73m2 had lower achievement of target RASi and MRA doses, with the lowest absolute use in patients with eGFR <30. Beta blockers were consistently prescribed across all heart failure phenotypes and kidney function.
Chen Hsiang Ma, Arthur Qi, Luke Gagnon, Kaiming Wang, Chandu Sadasivan, Anukul Ghimire, Matthew Cooper, Somkanya Tungsanga, Bonaventure Oguaju, Ben Vandermeer, Finlay A. McAlister, Aminu K. Bello, Gavin Y. Oudit   +12 more
wiley   +1 more source

Cardiac Pacing and Defibrillation in Children and Young Adults

, 2013
Harinder R. Singh, Anjan S. Batra, Seshadri Balaji   +2 more
openalex   +1 more source

LO08: Defibrillation energy dose during pediatric cardiac arrest: systematic review of human and animal model studies [PDF]

, 2019
Éric Mercier, Éléna Laroche, Ben Beck, Natalie Le Sage, Peter Cameron, Marcel Émond, Simon Berthelot, Biswadev Mitra, Julie Ouellet-Pelletier   +8 more
openalex   +1 more source

Defibrillation of soft porous metal-organic frameworks with electric fields

Science, 2017
A. Knebel, Benjamin Geppert, K. Volgmann, D. Kolokolov, D. Kolokolov, A. Stepanov, A. Stepanov, J. Twiefel, P. Heitjans, D. Volkmer, J. Caro   +10 more
semanticscholar   +1 more source

Transcriptomic and proteomic profiling shows dysregulated immune and metabolic pathways in arrhythmogenic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims Arrhythmogenic cardiomyopathy (ACM) is a hereditary heart disease characterized by fibrofatty myocardial replacement and a predisposition to malignant ventricular arrhythmias. The underlying pathomechanisms remain incompletely understood, and specific disease markers are sparse.
Deniz Akdis, Lukas Weidmann, Paolo Nanni, Anna Gaertner, Hendrik Milting, Peter Bode, Corinna Brunckhorst, Liang Chen, Felix C. Tanner, Frank Ruschitzka, Ardan M. Saguner, Firat Duru   +11 more
wiley   +1 more source

Portable medical status and treatment system [PDF]

A portable medical status and treatment system is discussed. The vital signs monitor includes electrocardiogram, respiration, temperature, blood pressure, alarm, and power subsystems, which are described.

core   +1 more source